Subject: How can we participate Phase 3 study of dexpramipexole
Dear Li,
I found some information about the clinic trial for Dexpramipexole.
Please see the attached article.
This trial will enroll patients in 28 states in US and 10 other
countries. I have not found if China is included in these 10
countries. You would better send them an email to ask directly. Below
I wrote an email for you, you can modify it and send it out directly to
ALSclinicaltrials@biogenidec.com
Your truly,
Changzhong
主题:我们怎样才能参加3期dexpramipexole的研究?
亲爱的李,
我发现了一些有关dexpramipexole临床试验的信息。
请参见所附的文章。
这项试验将招收美国28个州和10个其他国家的患者。我还没有发现是否中国也包含在10个国家之内。你最好发给他们一个电子邮件直接问一下。下面
我为你写一封邮件,你可以修改一下,并把它直接发给alsclinicaltrials@biogenidec.com
你的真正的,
changzhong
To:
ALSclinicaltrials@biogenidec.com
Dear Madam or Sir,
It is our pleasure to hear that Biogen Idec has launched the phase 3
trial of Dexpramipexole in ALS. We understand that the trial will be
conducted in 28 US states and 10 other countries. We do not know if
China was included in these 10 countries, and if yes, whom we should
contact to participate into this trial as volunteer patients.
Thank you for helping! We are looking forward to hearing from you soon!
Li Jiang
亲爱的先生或女士,
我们很高兴听到生物基因公司已经推出3期
Dexpramipexole对肌萎缩侧索硬化症的测试。我们知道测试将
在美国28个州和10个其他国家进行。我们不知道
是否中国包含在这10个国家之内,如果是的,我们患者志愿者应该
联系谁参与这试验?
谢谢你的帮助!我们期待着很快收到你的来信!
李强
The information in this e-mail is intended only for the person to whom it is
addressed. If you believe tSubject: How can we participate Phase 3 study of dexpramipexole
Dear Li,
I found some information about the clinic trial for Dexpramipexole.
Please see the attached article.
This trial will enroll patients in 28 states in US and 10 other
countries. I have not found if China is included in these 10
countries. You would better send them an email to ask directly. Below
I wrote an email for you, you can modify it and send it out directly to
ALSclinicaltrials@biogenidec.com
Your truly,
Changzhong
主题:我们怎样才能参加3期dexpramipexole的研究?
亲爱的李,
我发现了一些有关dexpramipexole临床试验的信息。
请参见所附的文章。
这项试验将招收美国28个州和10个其他国家的患者。我还没有发现是否中国也包含在10个国家之内。你最好发给他们一个电子邮件直接问一下。下面
我为你写一封邮件,你可以修改一下,并把它直接发给alsclinicaltrials@biogenidec.com
你的真正的,
changzhong
To:
ALSclinicaltrials@biogenidec.com
Dear Madam or Sir,
It is our pleasure to hear that Biogen Idec has launched the phase 3
trial of Dexpramipexole in ALS. We understand that the trial will be
conducted in 28 US states and 10 other countries. We do not know if
China was included in these 10 countries, and if yes, whom we should
contact to participate into this trial as volunteer patients.
Thank you for helping! We are looking forward to hearing from you soon!
Li Jiang
亲爱的先生或女士,
我们很高兴听到生物基因公司已经推出3期
Dexpramipexole对肌萎缩侧索硬化症的测试。我们知道测试将
在美国28个州和10个其他国家进行。我们不知道
是否中国包含在这10个国家之内,如果是的,我们患者志愿者应该
联系谁参与这试验?
谢谢你的帮助!我们期待着很快收到你的来信!
李强
The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, plese contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
:alsclinicaltrials@biogenidec.com
分享到
抱歉,系统响应超时,请稍后再试
· 支持中英、中日在线互译
· 支持网页翻译,在输入框输入网页地址即可
· 提供一键清空、复制功能、支持双语对照查看,使您体验更加流畅
his e-mail was sent to you in error and the e-mail
contains patient information, plese contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.
:alsclinicaltrials@biogenidec.com